Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatemeh Hadi-Nezhad

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|April 27, 2021
tSFM 1.0: tRNA Structure-Function MapperTravis J Lawrence, Fatemeh Hadi-Nezhad, Ivo Grosse, et al.
Plos Neglected Tropical Diseases|February 28, 2020
Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogensPaul Kelly, Fatemeh Hadi-Nezhad, Dennis Y Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trialJenell Volkov, Daniel Nunez, Tahseen Mozaffar, et al.
Blood|May 27, 2026
CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV TrialDaniel Nunez, Jason Stadanlick, Thomas Furmanak, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|April 27, 2021
tSFM 1.0: tRNA Structure-Function MapperTravis J Lawrence, Fatemeh Hadi-Nezhad, Ivo Grosse, et al.
Plos Neglected Tropical Diseases|February 28, 2020
Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogensPaul Kelly, Fatemeh Hadi-Nezhad, Dennis Y Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2024
Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trialJenell Volkov, Daniel Nunez, Tahseen Mozaffar, et al.
Blood|May 27, 2026
CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV TrialDaniel Nunez, Jason Stadanlick, Thomas Furmanak, et al.
Pageof 1